Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Lajos Géczi, G. Bodoky, György Rokszin, Ibolya Fábián, László Torday
Pathology & Oncology Research, 2020
Abstract
This research paper explore the methodology and findings associated with Pathology & Oncology Research. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).